CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PEARRL project trains early-stage researchers in drug development and regulatory processes to create better pharmaceutical formulations. By bridging academia and industry, it aims to streamline the approval of new drugs, ensuring quicker access to life-saving treatments for patients.
The European Pharma industry is a major contributor to EU well-being, both in public health and economic (sales >200 billion €/year) terms.
To maintain global leadership, it must respond to challenges from low-cost producers e.g.
China by bringing new drug molecules to market in a streamlined, cost-effective manner.
This strategy is underscored by recent initiatives of European regulators to expedite the approval of “breakthrough drugs” so patients can gain earlier access to life-saving drugs. T…
UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Frankfurt Am Main
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Greece, Athina
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Bath
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Windisch
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
